Exact Mass: 334.2486572
Exact Mass Matches: 334.2486572
Found 500 metabolites which its exact mass value is equals to given mass value 334.2486572,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Prostaglandin B2
Prostaglandin B2 (PGB2) is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Prostaglandin B2 (PGB2) is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207)
12-Keto-leukotriene B4
12-Keto-leukotriene B4 is formed when leukotriene B4 (LTB4) is metabolized by beta-oxidation. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 8632343, 9667737)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 12-Keto-leukotriene B4 is formed when leukotriene B4 (LTB4) is metabolized by beta-oxidation. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 8632343, 9667737)
Prostaglandin A2
Produced by the seminal vesicles, prostaglandins are a group of lipid compounds that are derived enzymatically from fatty acids. Technically hormones, the prostanoid class of fatty acid derivatives is a subclass of eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways. Prostaglandin A is a cyclopentenone and is an endogenous metabolite derived from arachidonic acid. It exhibits potent cellular anti-proliferative activity in vivo and in vitro. Excess PGA2 causes an accumulation in both S and G2/M, and a marked decrease in G1. There is also an increase in DNA content preceeding the G0/G1 peak (indicative of apoptotic body formation) mediated by changes in expression levels of Bax and Bcl-2. Produced by the seminal vessicals: Prostaglandins are a group of lipid compounds that are derived enzymatically from fattyacids. Technically a hormone, the prostanoid class of fatty acid derivatives is a subclass of eicosanoids. Prostaglandin A is cyclopentenone and endogenous metabolite derived from arachidonic acid. Exhibits potent cellular anti-proliferative activity in vivo and in vitro. Excess PGA2 causes an accumulation in both S and G2/M, and a marked decrease in G1. As well there is an increase in DNA content preceeding the G0/G1 peak (indicative of apoptic body formation) mediated by changes in expression levels of Bax and Bcl-2.
Prostaglandin-c2
This compound belongs to the family of Prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid.
Delta-12-Prostaglandin J2
Delta-12-Prostaglandin J2 (d12-PGJ2) is the ultimate metabolite of Prostaglandin D2 (PGD2). PGD2 is an unstable molecule and undergoes dehydration to form PGJ2 in aqueous solution, and is then converted to d12-PGJ2, in the presence of serum albumin or plasma. d12-PGJ2 forms a conjugate with the thiol of glutathione (GSH) and GSH suppresses the d12-PGJ2-induced HSP synthesis and subsequent inhibition of cell growth (HSPs are a set of proteins synthesized in response to heat shock or to other environmental stresses). d12-PGJ2 has been shown to stimulate alkaline phosphatase activity and calcification of human osteoblastic cells, the potency of the PGs being comparable to that of 1-a,25-dihydroxy vitamin D. d12-PGJ2 enhances the type-1 collagen synthesis in human osteoblasts during calcification. Thus, d12-PGJ2 modulates osteogenesis through induction of the syntheses of multiple proteins related to mineralization. Considering that PGD2 is a major arachidonate metabolite in bone marrow, d12-PGJ2, may be physiologically involved in the modulation of osteogenesis. d12-PGJ2 induces heme oxygenase, HO-l. Heme oxygenase is a key enzyme in heme catabolism, oxidatively clearing heme to yield biliverdin, iron and carbon monoxide. The biological function of this enzyme is the conversion of potentially toxic heme to bile and the recovery of the iron. Furthermore, carbon monoxide produced on the enzymatic degradation of heme has been suggested to function as a neural messenger. Two isozymes of heme oxygenase, HO-l and HO-2, have been identified. HO-2 is constitutively expressed, while HO-l is drastically induced in response to a variety of stresses, including heavy metals, heat shock and UV irradiation. (PMID: 8777585)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. delta-12-Prostaglandin J2 (d12-PGJ2) is the ultimate metabolite of Prostaglandin D2 (PGD2). PGD2 is an unstable molecule and undergoes dehydration to form PGJ2 in aqueous solution, and is then converted to d12-PGJ2, in the presence of serum albumin or plasma. d12-PGJ2 forms a conjugate with the thiol of glutathione (GSH) and GSH suppresses the d12-PGJ2-induced HSP synthesis and subsequent inhibition of cell growth (HSPs are a set of proteins synthesized in response to heat shock or to other environmental stresses). d12-PGJ2 has been shown to stimulate alkaline phosphatase activity and calcification of human osteoblastic cells, the potency of the PGs being comparable to that of 1-a,25-dihydroxy vitamin D. d12-PGJ2 enhances the type-1 collagen synthesis in human osteoblasts during calcification. Thus, d12-PGJ2 modulates osteogenesis through induction of the syntheses of multiple proteins related to mineralization. Considering that PGD2 is a major arachidonate metabolite in bone marrow, d12-PGJ2, may be physiologically involved in the modulation of osteogenesis. d12-PGJ2 induces heme oxygenase, HO-l. Heme oxygenase is a key enzyme in heme catabolism, oxidatively clearing heme to yield biliverdin, iron and carbon monoxide. The biological function of this enzyme is the conversion of potentially toxic heme to bile and the recovery of the iron. Furthermore, carbon monoxide produced on the enzymatic degradation of heme has been suggested to function as a neural messenger. Two isozymes of heme oxygenase, HO-l and HO-2, have been identified. HO-2 is constitutively expressed, while HO-l is drastically induced in response to a variety of stresses, including heavy metals, heat shock and UV irradiation. (PMID: 8777585) D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents
Lathyrol
Lathyrol is a natural product, and is used for cancer treatment. Lathyrol is a natural product, and is used for cancer treatment.
(ent-6alpha,7alpha)-6,7-Dihydroxy-16-kauren-19-oic acid
(ent-6alpha,7alpha)-6,7-Dihydroxy-16-kauren-19-oic acid is found in fruits. (ent-6alpha,7alpha)-6,7-Dihydroxy-16-kauren-19-oic acid is produced by Cucurbita maxima and in cell-free systems of other plants. Production by Cucurbita maxima and in cell-free systems of other plants. 6beta,7beta-Dihydroxykaurenoic acid is found in fruits and japanese pumpkin.
Tetrahydrodeoxycorticosterone
The neurosteroid allotetrahydrodeoxycorticosterone (THDOC) is an allosteric modulator of the GABA(A) receptor. Although the role of THDOC within the brain is undefined, recent studies indicate that stress induces THDOC to levels that can activate GABA(A) receptors. These results might have significant implications for human stress-sensitive conditions such as epilepsy, post-traumatic stress disorder and depression. (PMID 12628349) [HMDB] The neurosteroid allotetrahydrodeoxycorticosterone (THDOC) is an allosteric modulator of the GABA(A) receptor. Although the role of THDOC within the brain is undefined, recent studies indicate that stress induces THDOC to levels that can activate GABA(A) receptors. These results might have significant implications for human stress-sensitive conditions such as epilepsy, post-traumatic stress disorder and depression. (PMID 12628349). D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D018377 - Neurotransmitter Agents > D000081227 - Neurosteroids 3α,21-Dihydroxy-5α-pregnan-20-one (THDOC), an endogenous neurosteroid, is a positive modulator of GABAA receptors. 3α,21-Dihydroxy-5α-pregnan-20-one potentiates neuronal response to low concentrations of GABA at α4β1δ GABAA receptors in vitro.
Emopamil
Emopamil is a drug that is a competitive inhibitor of 3β-hydroxysteroid-Δ8-Δ7-isomerase. 3β-hydroxysteroid-Δ8-Δ7-isomerase is involved in the formation of cholesterol from lanosterol. Emopamil is a calcium channel blocker. [HMDB] Emopamil is a drug that is a competitive inhibitor of 3β-hydroxysteroid-Δ8-Δ7-isomerase. 3β-hydroxysteroid-Δ8-Δ7-isomerase is involved in the formation of cholesterol from lanosterol. Emopamil is a calcium channel blocker. C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
17alpha-Hydroxypregnanolone
A 17alpha-hydroxy steroid that is 3alpha-hydroxy-5beta-pregnan-20-one carrying an additional hydroxy group at position 17alpha.
17beta-Hydroxy-2alpha-(methoxymethyl)-5alpha-androstan-3-one
17beta-Hydroxy-2alpha-(hydroxymethyl)-17-methyl-5alpha-androstan-3-one
3beta-Hydroxy-4alpha-methylsteroid-4beta-carboxylate
ent-16beta-Methoxy-19-kauranoic acid
ent-16beta-Methoxy-19-kauranoic acid is found in alcoholic beverages. ent-16beta-Methoxy-19-kauranoic acid is a constituent of Annona glabra (pond apple) Constituent of Annona glabra (pond apple). ent-16b-Methoxy-19-kauranoic acid is found in alcoholic beverages and fruits.
Lycopersiconol
Lycopersiconol is found in garden tomato. Lycopersiconol is isolated from Lycopersicon esculentum (tomato Isolated from Lycopersicon esculentum (tomato). Lycopersiconol is found in garden tomato.
1-(3,5-Dihydroxyphenyl)-2-pentadecanone
1-(3,5-Dihydroxyphenyl)-2-pentadecanone is found in cereals and cereal products. 1-(3,5-Dihydroxyphenyl)-2-pentadecanone is isolated from etiolated rice seedlings. Isolated from etiolated rice seedlings. 1-(3,5-Dihydroxyphenyl)-2-pentadecanone is found in cereals and cereal products.
[10]-Paradol
Constituent of Amomum melegueta (grains of paradise). [10]-Paradol is found in alcoholic beverages and herbs and spices. [10]-Paradol is found in alcoholic beverages. [10]-Paradol is a constituent of Amomum melegueta (grains of paradise).
Isolinderenolide
Constituent of Lindera benzoin (spicebush) berries. Isolinderenolide is found in tea, herbs and spices, and fruits. Isolinderenolide is found in fruits. Isolinderenolide is a constituent of Lindera benzoin (spicebush) berries.
2-((5-(Diethylamino)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)(hexyl)amino)ethanol
Pregnan-20-one, 3,17-dihydroxy-, (3alpha)-
Acetamide, 2-(diethylamino)-N-(2-(octyloxy)phenyl)-
dihydrodeoxycorticosterone
(8R,9S,10S,13S,14S,17R)-17-Ethyl-3,17-dihydroxy-10,13-dimethyl-3,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-2-one
1-(3,3-Dimethyloxiranyl)-7-hydroxy-3,7-dimethyl-3,5,8-nonatrienyl ester 2-methyl-2-butenoic acid
12,20-Dihydroxy-3alpha,4alpha,15,16-bisepoxy-8beta,10betaH-ent-cleroda-13(16),14-diene
Decahydro-alpha,4a-dimethyl-8-methylene-7-[(2-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid
Decahydro-alpha,4a-dimethyl-8-methylene-7-[(3-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid
(13R)-13-Hydroxy-labda-8(14).15-dien-19-saeure-methylester, Cupressinsaeure-methylester|Cupressinsaeure-methylester|Methyl-13beta-hydroxy-8(17),E-13-labdadien-19-oat
3-Ketone,15-carboxylic acid,Me ester-5(10)-Halimene-3,15-diol
methyl 15-oxolabd-8-en-19-oate|Methylimbricataloat
1,19-dihydroxy-12-oxo-smallantha-2Z,6Z,10E,13E-tetraene
(-)-methyl-13-hydroxycleroda-3,14-diene-18-carboxylate
(12Z)-6,7:9,10:15,16-trisepoxyhenicosa-12,20-diene|6,7;12,13:15,16-Triepoxide,18,19-dihydro-(all-Z)-1,6,9,12,15,18-Heneicosahexaene
(3Z,4S,5S)-3-(15-Hexadecynylidene)dihydro-4-hydroxy-5-methyl-2(3H)-furanone|Dihydromahubynolid B|dihydromahubynolide B
(12S)-hydroxyeicosatetraenoic acid|(S)-12-Hydroxy-5,8,14-cis-10-trans-eicosatetraen-carbonsaeure-methylester|(S)-methyl (5Z,8Z,10E,14Z)-12-hydroxyeicosa-5,8,10,14-tetraenoate|12(S)-HETE methyl ester|methyl (5Z,8Z,10E,12S,14Z)-12-hydroxyeicosa-5,8,10,14-tetraenoate|methyl 12(S)-hydroxy-5(Z),8(Z),10(E),14(Z)-eicosatetraenoate|methyl 12S-hydroxyeicosa-5Z,8Z,10E,14Z-tetraenoate
16-Hydroxy-trans-labda-8(14).13(15)-dien-16-saeure-methylester, Isocupressinsaeure-methylester|Isocupressinsaeure-methylester|methyl 12alpha-hydroxyabietate|methyl cupressate|methyl isocupressate|methyl isopressate|Methyl-15-hydroxy-8(17)-(E)-13-labdadien-19-oat|Methylisocompressat|Methylisocupressat
(3beta,5alpha,14beta,17alpha)-3,14-Dihydroxypregnan-20-one
3alpha,20-Dihydroxy-5beta.20alphaH-13(17=>20)-abeo-pregnanon-(17)|3alpha,20-dihydroxy-5beta.20alphaH-13(17=>20)-abeo-pregnanone-(17)
1,19-dihydroxy-12-oxo-smallantha-2Z,6Z,10E,14(21)-tetraene
methyl 13S-hydroxy-1(10),14-ent-halimadiene-18-oate
Me ester-(5Z,7E,9S,11Z,14Z)-9-Hydroxy-5,7,11,14-eicosatetraenoic acid
(12S,13S,15R)-12,15-epoxy-15-methoxy-ent-labda-8(17)-en-16-al|turraeanin E
3beta,4alpha-dihydroxypregnan-16-one|3beta,4alpha-diihydroxy-5alpha-pregnan-16-one
(5Z,13E,15S)-15-hydroxy-9-oxo-prosta-5,8(12),13-trien-1-oic acid
2-hydroxy-5-methoxy-3-(Z-8-tridecenyl)-1,4-benzoquinone|5-methoxy-2-hydroxy-3-(Z-8-tridecenyl)-1,4-benzoquinone|ardisianone B
13,14-dihydro-marrubiagenine|13,14-dihydromarrubiagenine
(6E,10E)-3,12-dihydroxy-3,7,11,15-tetramethyl-1,6,10,14-hexadecatetraen-5,13-dione
7beta-hydroxy-11beta,16beta-epoxy-ent-kauran-19-oic acid
(ent-15R)-form-15,16-Dihydroxy-3-erythroxylene-2,7-dione|2,7-dioxofagonene
(2S)-serrulat-14-ene-2,7,8,20-tetraol|2,7,8,20-tetrahydroxyserrulat-14-ene
isovaleryloxy-germacra-trans,trans-1(10),4,11-trien-12-oic acid
2-Hydroxy-5-methoxy-3-tridecenyl-benzochinon|2-Hydroxy-5-methoxy-3-tridecenylbenzochinon
17-Hydroxy-16alpha-(-)-kauran-19-saeure-methylester|Methyl ent-17-hydroxykauran-19-oate|methyl ent-17-hydroxykauran-19-oic acid|methyl-17-hydroxy-16alpha-(-)-kauran-19-oate
9,10-dihydroxy-9,10-secoabieta-8,11,13-trien-18-oic acid|abiesadine B
3-(7-hexadecenylidene)dihydro-4-hydroxy-5-methylene-2(3h)-furanone
15-(3-hydroxyisovaleryloxy)-cyperen-3-one|15-<3-hydroxyisovaleryloxy>-cyperen-3-one
ent-1beta-hydroxykaur-16beta(H)-15-one-19-oic acid
6alpha,13beta-dihydroxy-7-oxoabieta-8(14)-en-19-al
(16alpha)-17-hydroxy-ent-atisan-19-oic acid methyl ester
13-(3,4-Methylene-dioxyphenyl)-tridecanoic acid|13-(3,4-methylenedioxyphenyl)-tridecanoic acid|13-(3,4-methylenedioxyphenyl)tridecanoic acid
12-(3-hydroxyisovaleryloxy)-guaia-4,11-diene-3-one|12-<3-hydroxyisovaleryloxy>-guaia-4,11-diene-3-one
14-Angeloyl 鈥樎?6alpha,7beta,8alpha)-6,7-Epoxy-3(15)-caryophyllene-8,14-diol
(20R)-5alpha-pregn-9(11)ene-3beta,6alpha,20-triol|asterogenol
Me ester-(5Z,8Z,11R,12E,14Z)-11-Hydroxy-5,8,12,14-eicosatetraenoic acid
2-Oxopopulifolinsaeure-methylester|methyl ester of 2-oxopopulifolic acid|oxopopulifolic acid methyl ester
15-Carboxylic acid,Me ester-(ent-13E)-8(17),13-Labdadien-15,18-diol
3alpha,17alpha-Dihydroxy-17beta-methyl-D-homo-5beta-androstan-17a-on|3alpha,17alpha-dihydroxy-17beta-methyl-D-homo-5beta-androstan-17a-one|3alpha,20-Dihydroxy-5beta.20alphaH-16(17=>20)-abeo-pregnanon-(17)
siegesmethyethericacid
(-)-7beta-hydroxy-8alpha-methoxydeepoxysarcophytoxide
15-hydroxy-15-methoxylabda-8(17),12(E)-dien-16-al|aframolin A
7-O-methylpedinophyllol H|7beta-methoxy-1beta,14alpha-dihydroxy-ent-pimara-8,15-diene
(13beta,14alpha)-14-methoxyabiet-8-en-18-oic acid|(1R,4aS,7S,8S,10aR)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-8-methoxy-1,4a-dimethyl-7-(1-methylethyl)phenanthrene-1-carboxylic acid|14-O-methylsuaveolic acid
15,16-Dihydro-Mahubynolide|Mahubenolid|mahubenolide
19-hydroxy-cis-cleroda-3,13E-dien-15-oic acid (ent-5alpha-form)|deserticolic acid
(3R)-8-hydroxy-6-methoxy-3-undecyl-3,4-dihydroisocoumarin
12,13,14,15-Tetradehydro(E,E-)-5-Hexadecyl-5-methyoxy-2(5H)-furanone
3-Ac-(3beta,5alpha,13alpha,16alpha)-Androstane-3,16-diol
2??-Hydroxy-3,13-clerodadien-15-oic acid methyl ester
(5S,6E,8Z,11Z,14Z)-5-Hydroxy-6,8,11,14-eicosatetraenoic acid|5-Hydroxy-6,8,11,14-eicosatetraenoic acid
methyl 3beta-hydroxy-4,18-dehydro-3,4-dihydrokolavenoate
1-acetyl-5-(1-acetyl-piperidin-2-ylmethyl)-7-methyl-decahydro-quinoline|N,N-Diacetylphlegmarin
(+)-hyperaspine|(-)-(3S,4aS,6R,8S)-hyperaspine|hyperaspine|rel-(3R,4aR,6S,8R)-6-hydroxy-3-methyl-8-pentylperhydropyrido[1,2-c][1,3]oxazine 6-pyrrole-2-carboxylate
Methyl 3,4a,7,10a-tetramethyl-3-vinyldodecahydro-1H-benzo[f]chromene-7-carboxylate #
15d-PGJ2-[d4]
CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0219.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0219.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0219.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
PGB2-[d4]
CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0220.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0220.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0220.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
leukotriene b5
A leukotriene composed of (6Z,8E,10E,14Z,17Z)-icosapentaenoic acid carrying (5S)- and (12R)-hydroxy substituents.
1,10a-dihydroxy-4,4,7,11b-tetramethyl-1,2,3,4a,5,6,6a,7,11,11a-decahydronaphtho[2,1-f][1]benzofuran-9-one_major
14-(hydroxymethyl)-5,9-dimethyl-15-oxapentacyclo[11.3.1.0¹,¹⁰.0⁴,⁹.0¹⁴,¹⁶]heptadecane-5-carboxylic acid_major
4-[2-[(1R,4aS,5R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-2H-furan-5-one_major
(E)-5-[(1S,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-(hydroxymethyl)-2-oxopent-3-enoic acid_81.6\\%
(E)-5-[(1S,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-(hydroxymethyl)-2-oxopent-3-enoic acid_major
5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5,14-dicarboxylic acid_major
5,9-dimethyltetracyclo[11.2.1.0¹,¹?.0?,?]hexadecane-5,14-dicarboxylic acid
12(S)-HpEPE
A 12-HPEPE in which the hydroperoxy group at positions 12 has S-configuration.
bicyclo-PGE2
THDOC
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D018377 - Neurotransmitter Agents > D000081227 - Neurosteroids 3α,21-Dihydroxy-5α-pregnan-20-one (THDOC), an endogenous neurosteroid, is a positive modulator of GABAA receptors. 3α,21-Dihydroxy-5α-pregnan-20-one potentiates neuronal response to low concentrations of GABA at α4β1δ GABAA receptors in vitro.
Lycopersiconol
Vaginatin
8alpha-8-Hydroxy-12-oxo-13-abieten-18-oic acid
ent-16b-Methoxy-19-kauranoic acid
(ent-16betaOH)-16,17-Dihydroxy-9(11)-kauren-19-oic acid
Dehydropinifolic acid
phytocassane B
Cymatherol C
Ectocarpin C
3-(n-acetylamino)-5-(n-decyl-n-methylamino)benzyl alcohol
Levemopamil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
4-(TRANS-4-(2-(TRANS-4-ETHYLCYCLOHEXYL)ETHYL)CYCLOHEXYL)-1,2-DIFLUOROBENZENE
oxiran-2-ylmethyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
trans,trans-4-(3,4-Difluorophenyl)-4-butylbicyclohexyl
Fenalamide
C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant
(4S,4S)-2,2-Cyclohexylidenebis[4-tert-butyl-4,5-dihydrooxazole],99\\%e.e.
N-[11-(Trimethoxysilyl)undecyl]-1,2-ethanediamine
C16H38N2O3Si (334.26515579999995)
tert-butyl N-[[1-benzyl-4-(hydroxymethyl)piperidin-4-yl]methyl]carbamate
Acetamide, 2-(diethylamino)-N-(2-(octyloxy)phenyl)-
Z,Z,Z-8,9-Epoxyeicosa-5,11,14-trienoic acid, methyl ester
2-[(1S,3R)-3-hydroxycyclohexyl]-5-(8-hydroxy-2-methyloctan-2-yl)phenol
(4As,5S,8aS)-8a-(1,3-dioxolan-2-yl)-2,5-dimethyl-5-(4-methylpent-3-enyl)-3,4,4a,6,7,8-hexahydro-2H-naphthalen-1-one
Pregnan-20-one, 3,17-dihydroxy-, (3alpha)-
Fusicocca-1,10(14)-diene-16-(hydroxymethyl)-3,8beta-diol
(8R,9S,10S,13S,14S,17R)-17-Ethyl-3,17-dihydroxy-10,13-dimethyl-3,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-2-one
oxiran-2-ylmethyl (9E,12E,15E)-octadeca-9,12,15-trienoate
Methyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoate
7-(2-Ethyl-1-piperidinyl)-5-methyl-2-(3-methylphenyl)pyrazolo[1,5-a]pyrimidine
1-cyclohexyl-2-(1H-imidazol-2-ylmethyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole
2-[(1R,3S)-3-hydroxycyclohexyl]-5-(8-hydroxy-2-methyloctan-2-yl)phenol
(3R,5Z,7E,9Z,18E)-3-hydroxy-18-methylicosa-5,7,9,18-tetraenoic acid
[1-Carboxy-3-(3-hexanoyloxy-2-hydroxypropoxy)propyl]-trimethylazanium
Emopamil
C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
soppiline A
A hydroxy monocarboxylic acid that is icosanoic acid carrying a hydroxy group at position 3R, methyl group at position 18, cis double bonds at positions 5 and 9, and trans double bonds at positions 7 and 18.
5α-Pregnane-3β,6α-diol-20-one
5α-Pregnane-3β,6α-diol-20-one is a mitogenic metabolite of progesterone, and it can be produced in starved androgen-responsive prostate cancer cells.
1-{6,7-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl}ethanone
(3e)-3-(hexadec-15-en-1-ylidene)-4-hydroxy-5-methylideneoxolan-2-one
3-[(7z)-hexadec-7-en-1-yl]-4-methylfuran-2,5-dione
(3as,5r,6as)-5,6a-diethyl-5-[(1e,4r,5e)-4-ethyl-2-methylocta-1,5-dien-1-yl]-dihydro-3h-furo[3,2-b]furan-2-one
methyl 12-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoate
3-(hexadec-7-en-1-ylidene)-4-hydroxy-5-methylideneoxolan-2-one
(3z,4r)-3-[(7e)-hexadec-7-en-1-ylidene]-4-hydroxy-5-methylideneoxolan-2-one
methyl (2e,6e,10e)-12-hydroxy-6,10-dimethyl-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trienoate
methyl (1s,4ar,5s,8ar)-1,4a-dimethyl-5-[(3r)-3-methyl-5-oxopentyl]-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
methyl 2-[(1s,4ar,5'r,8ar)-2,5,5,5',8a-pentamethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-yl]acetate
13-hydroxy-5,9,10,13-tetramethyltetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
4-hydroxy-3,5-dimethyl-6-[(2z,4s,6s,8s)-4,6,8-trimethylundec-2-en-2-yl]pyran-2-one
methyl 13-(hydroxymethyl)-5,9-dimethyltetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
5-(6-hydroxy-4-methylhex-4-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
methyl 5-(3-hydroxy-3-methylpent-4-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
(2z,5e)-2-[(4e)-6-methoxy-4-methylhex-4-en-1-ylidene]-6,10-dimethylundeca-5,9-dienoic acid
methyl (2e)-5-[(1s,4ar,5r,8ar)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-enoate
3-(hexadec-7-en-1-yl)-4-hydroxy-5-methylidenefuran-2-one
(1r,3as,3br,5as,7r,8r,9as,9bs,11ar)-1-ethyl-7,8-dihydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-2-one
2α-hydroxy-3,13-clerodadien-15-oicacid methylester
{"Ingredient_id": "HBIN005283","Ingredient_name": "2\u03b1-hydroxy-3,13-clerodadien-15-oicacid methylester","Alias": "NA","Ingredient_formula": "C21H34O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9919","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2β-hydroxy-3,13-clerodadien-15-oicacid methylester
{"Ingredient_id": "HBIN005392","Ingredient_name": "2\u03b2-hydroxy-3,13-clerodadien-15-oicacid methylester","Alias": "NA","Ingredient_formula": "C21H34O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9920","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2β-hydroxy-9-epi-ent-labda-8(17),13(z)-dien-15-oicacid
{"Ingredient_id": "HBIN005397","Ingredient_name": "2\u03b2-hydroxy-9-epi-ent-labda-8(17),13(z)-dien-15-oicacid","Alias": "NA","Ingredient_formula": "C21H34O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10075","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-pregnene-3β,17α,20α-triol
{"Ingredient_id": "HBIN011882","Ingredient_name": "5-pregnene-3\u03b2,17\u03b1,20\u03b1-triol","Alias": "NA","Ingredient_formula": "C21H34O3","Ingredient_Smile": "CC(C1(CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "17789","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-Tetradecanesulfonic acid,butyl ester
C18H38O3S (334.25415180000005)
{"Ingredient_id": "HBIN012824","Ingredient_name": "6-Tetradecanesulfonic acid,butyl ester","Alias": "NA","Ingredient_formula": "C18H38O3S","Ingredient_Smile": "CCCCCCCCC(CCCCC)S(=O)(=O)OCCCC","Ingredient_weight": "334.6 g/mol","OB_score": "21.3623979","CAS_id": "NA","SymMap_id": "SMIT07243","TCMID_id": "NA","TCMSP_id": "MOL005494","TCM_ID_id": "NA","PubChem_id": "551402","DrugBank_id": "NA"}
(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-diol
(1s,4s,5s,9r,10r,12s,13s)-13-hydroxy-5,9,10,13-tetramethyltetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
(2e,5e)-2-[(4e)-6-methoxy-4-methylhex-4-en-1-ylidene]-6,10-dimethylundeca-5,9-dienoic acid
(1r,3as,3br,5as,7r,8r,9as,9bs,11as)-1-ethyl-7,8-dihydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-2-one
6-methoxy-3-undecyl-3,4-dihydro-1h-2-benzopyran-8-ol
(1r,7r,8s,9as,11as)-1-ethyl-7,8-dihydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-2-one
methyl (1s,4r,5r,9s,10s,13r,14r)-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylate
(3ar,5s,6ar)-5,6a-diethyl-5-[(1e,5e)-4-ethyl-2-methylocta-1,5-dien-1-yl]-dihydro-3h-furo[3,2-b]furan-2-one
(3e,4r)-3-[(7z)-hexadec-7-en-1-ylidene]-4-hydroxy-5-methylideneoxolan-2-one
(1s,3as,3br,5as,7r,9as,9bs,11as)-7-hydroxy-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-2-one
(1r,2e,4r,7s,8r,9s)-12-isopropyl-4-(methoxymethyl)-1,8-dimethyltricyclo[9.3.0.0³,⁷]tetradeca-2,11-diene-4,9-diol
methyl 2-[(1r,4as,5'r,8as)-2,5,5,5',8a-pentamethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-yl]acetate
methyl 12-hydroxy-6,10-dimethyl-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trienoate
1-(1-hydroxyethyl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthrene-5,7-diol
4,6-dimethyl-3-(tetradec-12-enoyl)-5,6-dihydropyran-2-one
12-isopropyl-4-(methoxymethyl)-1,8-dimethyltricyclo[9.3.0.0³,⁷]tetradeca-2,11-diene-4,9-diol
methyl (3r)-5-[(1s,4as,8ar)-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-3-methylpentanoate
(2s,3s,5r)-2-{[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-5-methoxyoxolane-3-carbaldehyde
methyl (3r)-5-[(1s,2r,4ar,8ar)-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-3-methylpentanoate
methyl (3r)-5-[(4ar,8as)-2,5,5,8a-tetramethyl-3-oxo-4a,6,7,8-tetrahydro-4h-naphthalen-1-yl]-3-methylpentanoate
3-(hexadec-15-en-1-ylidene)-4-hydroxy-5-methylideneoxolan-2-one
methyl (1s,4ar,5s,8as)-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
methyl 5-[5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-enoate
methyl 2-{2,5,5,5',8a-pentamethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-yl}acetate
(3r)-6-methoxy-3-undecyl-3,4-dihydro-1h-2-benzopyran-8-ol
methyl 5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
(1r,4ar,4br,7s,10ar)-7-hydroxy-1-(hydroxymethyl)-7-isopropyl-1,4a,10a-trimethyl-3,4,4b,5,6,10-hexahydro-2h-phenanthren-9-one
(3r,4as,6as,8r,10ar,10bs)-3-ethenyl-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-8-yl formate
methyl 2-{4'-ethenyl-1,3,3,4'-tetramethyl-2'-oxo-[1,1'-bi(cyclohexane)]-2-yl}acetate
methyl (1s,4ar,5s,8ar)-5-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
5,6a-diethyl-5-(4-ethyl-2-methylocta-1,5-dien-1-yl)-dihydro-3h-furo[3,2-b]furan-2-one
methyl 2-[(1s,1'r,2s,4's)-4'-ethenyl-1,3,3,4'-tetramethyl-2'-oxo-[1,1'-bi(cyclohexane)]-2-yl]acetate
methyl 5-(2-hydroxy-2,5,5,8a-tetramethyl-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl)-3-methylpent-2-enoate
(1s,3as,3bs,5s,5as,7s,9as,11as)-1-(1-hydroxyethyl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthrene-5,7-diol
(3z,4r)-3-[(7z)-hexadec-7-en-1-ylidene]-4-hydroxy-5-methylideneoxolan-2-one
methyl (2e,6e,10e,12s)-12-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoate
(6s)-4,6-dimethyl-3-[(12e)-tetradec-12-enoyl]-5,6-dihydropyran-2-one
methyl (1r,4ar,5s,8ar)-5-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
methyl 5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylate
2-(6-methoxy-4-methylhex-4-en-1-ylidene)-6,10-dimethylundeca-5,9-dienoic acid
methyl (1r,4as,7s,8s,10ar)-8-hydroxy-7-isopropyl-1,4a-dimethyl-2,3,4,5,6,7,8,9,10,10a-decahydrophenanthrene-1-carboxylate
methyl 5-(1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl)-3-methylpentanoate
(3z,4r,5s)-3-(hexadec-15-yn-1-ylidene)-4-hydroxy-5-methyloxolan-2-one
methyl (1s,4s,5r,9s,10r,13r,14r)-14-hydroxy-5,9,14-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
(3e,4r,5s)-3-(hexadec-15-yn-1-ylidene)-4-hydroxy-5-methyloxolan-2-one
14-(hydroxymethyl)-14-methoxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carbaldehyde
(2r,3r)-2-(pent-4-en-1-yl)-3-[(2z)-4-[(2r,3r)-3-{[(2r,3r)-3-pentyloxiran-2-yl]methyl}oxiran-2-yl]but-2-en-1-yl]oxirane
(3e,4s,5s)-3-(hexadec-15-yn-1-ylidene)-4-hydroxy-5-methyloxolan-2-one
1-[(1s,3as,3br,5ar,6s,7s,9ar,9bs,11as)-6,7-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone
(1r,3as,3br,5as,7r,8s,9as,9bs,11as)-1-ethyl-7,8-dihydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-2-one
(3z,4r)-3-(hexadec-15-en-1-ylidene)-4-hydroxy-5-methylideneoxolan-2-one
1-{2,7-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl}ethanone
methyl 5-(3-hydroxy-3-methylpent-4-en-1-yl)-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate
methyl (1s,4ar,5s,8ar)-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
(1r,3as,3br,5ar,6s,7r,9ar,9bs,11as)-1-ethyl-6,7-dihydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-2-one
(1r,4s,4ar,8ar)-4-hydroxy-6-isopropyl-4,8a-dimethyl-1,2,3,4a,5,8-hexahydronaphthalen-1-yl (2e)-3-methylpent-2-enoate
methyl 5-[4a-(hydroxymethyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate
(1r,3as,3br,5ar,6s,7s,9ar,9bs,11as)-1-ethyl-6,7-dihydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-2-one
4-hydroxy-3,5-dimethyl-6-[(2e,4s,6s,8s)-4,6,8-trimethylundec-2-en-2-yl]pyran-2-one
methyl 5-(2,5,5,8a-tetramethyl-3-oxo-4a,6,7,8-tetrahydro-4h-naphthalen-1-yl)-3-methylpentanoate
1-(1-hydroxyethyl)-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-diol
(1r,4s,4ar,8ar)-4-hydroxy-6-isopropyl-4,8a-dimethyl-1,2,3,4a,7,8-hexahydronaphthalen-1-yl (2e)-3-methylpent-2-enoate
methyl 14-hydroxy-5,9,14-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
3-ethenyl-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-8-yl formate
(3r,5s)-3-(hexadec-9-en-7-yn-1-yl)-5-(hydroxymethyl)oxolan-2-one
2-amino-3-{[3-amino-6-(aminomethyl)oxan-2-yl]oxy}-6-methoxy-5-(methylamino)cyclohexane-1,4-diol
methyl (1s,4ar,5s,8ar)-5-[(3z)-5-hydroxy-3-methylpent-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
(10s,11s,15as)-10-methoxy-3,6,10,14-tetramethyl-2h,4h,5h,8h,9h,11h,12h,13h,15ah-cyclotetradeca[b]furan-11-ol
methyl 14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
(3r,5s)-3-[(9z)-hexadec-9-en-7-yn-1-yl]-5-(hydroxymethyl)oxolan-2-one
methyl 5-(6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-3-methylpent-2-enoate
methyl (1s,4ar,5s,8ar)-1,4a-dimethyl-5-[(3s)-3-methyl-5-oxopentyl]-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
1-ethyl-6,7-dihydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-2-one
methyl (2e)-5-[(1r,2r,4ar,8as)-2-hydroxy-2,5,5,8a-tetramethyl-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-3-methylpent-2-enoate
methyl 2-[(1r,4ar,5'r,8as)-2,5,5,5',8a-pentamethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-yl]acetate
methyl 5-(7-hydroxy-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)-3-methylpent-2-enoate
(3s,4as,6r,8s)-3-methyl-8-pentyl-octahydropyrido[1,2-c][1,3]oxazin-6-yl 1h-pyrrole-2-carboxylate
(1s,4s,5r,9s,10r,13r,14r)-14-(hydroxymethyl)-14-methoxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carbaldehyde
10-methoxy-3,6,10,14-tetramethyl-2h,4h,5h,8h,9h,11h,12h,13h,15ah-cyclotetradeca[b]furan-11-ol
{[(3s,6r,8ar,12ar)-6-hexyl-dodecahydropyrido[2,1-j]quinolin-3-yl]sulfanyl}formonitrile
C20H34N2S (334.24425640000004)